Miragen Therapeutics Inc, formerly Signal Genetics Inc is a commercial stage, molecular genetic diagnostic company focused on providing diagnostic services that help physicians make decisions concerning the care of their patients suffering from cancer.
Our STA Research today shows that the stock is due for a 100% increase in it’s stock valuation within a 6 to 12 month duration.  Yahoo Finance Analyst Report indicates a 197% increase. Our STA Research rating indicates the stock as a Very Strong Buy with Bearish near term sentiment.
